130 related articles for article (PubMed ID: 15713677)
1. Palmitoylated cysteine 192 is required for RhoB tumor-suppressive and apoptotic activities.
Wang DA; Sebti SM
J Biol Chem; 2005 May; 280(19):19243-9. PubMed ID: 15713677
[TBL] [Abstract][Full Text] [Related]
2. RhoB, not RhoA, represses the transcription of the transforming growth factor beta type II receptor by a mechanism involving activator protein 1.
Adnane J; Seijo E; Chen Z; Bizouarn F; Leal M; Sebti SM; Muñoz-Antonia T
J Biol Chem; 2002 Mar; 277(10):8500-7. PubMed ID: 11741970
[TBL] [Abstract][Full Text] [Related]
3. RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: evidenced in vivo by an anti-farnesyl cysteine antibody.
Baron R; Fourcade E; Lajoie-Mazenc I; Allal C; Couderc B; Barbaras R; Favre G; Faye JC; Pradines A
Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11626-31. PubMed ID: 11027361
[TBL] [Abstract][Full Text] [Related]
4. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
Wang L; Yang L; Luo Y; Zheng Y
J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
[TBL] [Abstract][Full Text] [Related]
5. Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice.
Chen Z; Sun J; Pradines A; Favre G; Adnane J; Sebti SM
J Biol Chem; 2000 Jun; 275(24):17974-8. PubMed ID: 10770919
[TBL] [Abstract][Full Text] [Related]
6. Farnesylated RhoB prevents cell cycle arrest and actin cytoskeleton disruption caused by the geranylgeranyltransferase I inhibitor GGTI-298.
Allal C; Pradines A; Hamilton AD; Sebti SM; Favre G
Cell Cycle; 2002; 1(6):430-7. PubMed ID: 12548020
[TBL] [Abstract][Full Text] [Related]
7. Modulation of TGFβ/Smad signaling by the small GTPase RhoB.
Livitsanou M; Vasilaki E; Stournaras C; Kardassis D
Cell Signal; 2018 Aug; 48():54-63. PubMed ID: 29705334
[TBL] [Abstract][Full Text] [Related]
8. Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells.
Mazières J; Tillement V; Allal C; Clanet C; Bobin L; Chen Z; Sebti SM; Favre G; Pradines A
Exp Cell Res; 2005 Apr; 304(2):354-64. PubMed ID: 15748883
[TBL] [Abstract][Full Text] [Related]
9. XPLN, a guanine nucleotide exchange factor for RhoA and RhoB, but not RhoC.
Arthur WT; Ellerbroek SM; Der CJ; Burridge K; Wennerberg K
J Biol Chem; 2002 Nov; 277(45):42964-72. PubMed ID: 12221096
[TBL] [Abstract][Full Text] [Related]
10. Palmitoylation of the human prostacyclin receptor. Functional implications of palmitoylation and isoprenylation.
Miggin SM; Lawler OA; Kinsella BT
J Biol Chem; 2003 Feb; 278(9):6947-58. PubMed ID: 12488443
[TBL] [Abstract][Full Text] [Related]
11. Ras and RhoA suppress whereas RhoB enhances cytokine-induced transcription of nitric oxide synthase-2 in human normal liver AKN-1 cells and lung cancer A-549 cells.
Delarue FL; Taylor BS; Sebti SM
Oncogene; 2001 Oct; 20(45):6531-7. PubMed ID: 11641777
[TBL] [Abstract][Full Text] [Related]
12. EGFR, ErbB2 and Ras but not Src suppress RhoB expression while ectopic expression of RhoB antagonizes oncogene-mediated transformation.
Jiang K; Delarue FL; Sebti SM
Oncogene; 2004 Feb; 23(5):1136-45. PubMed ID: 14647415
[TBL] [Abstract][Full Text] [Related]
13. The 5-hydroxytryptamine(4a) receptor is palmitoylated at two different sites, and acylation is critically involved in regulation of receptor constitutive activity.
Ponimaskin EG; Heine M; Joubert L; Sebben M; Bickmeyer U; Richter DW; Dumuis A
J Biol Chem; 2002 Jan; 277(4):2534-46. PubMed ID: 11706023
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of the small GTPase RhoB gene by TGF{beta}-induced signaling pathways.
Vasilaki E; Papadimitriou E; Tajadura V; Ridley AJ; Stournaras C; Kardassis D
FASEB J; 2010 Mar; 24(3):891-905. PubMed ID: 19890017
[TBL] [Abstract][Full Text] [Related]
15. Geranylgeranylated RhoB mediates suppression of human tumor cell growth by farnesyltransferase inhibitors.
Du W; Prendergast GC
Cancer Res; 1999 Nov; 59(21):5492-6. PubMed ID: 10554025
[TBL] [Abstract][Full Text] [Related]
16. ROCK I-mediated activation of NF-kappaB by RhoB.
Rodriguez PL; Sahay S; Olabisi OO; Whitehead IP
Cell Signal; 2007 Nov; 19(11):2361-9. PubMed ID: 17728102
[TBL] [Abstract][Full Text] [Related]
17. RhoA biological activity is dependent on prenylation but independent of specific isoprenoid modification.
Solski PA; Helms W; Keely PJ; Su L; Der CJ
Cell Growth Differ; 2002 Aug; 13(8):363-73. PubMed ID: 12193475
[TBL] [Abstract][Full Text] [Related]
18. Geranylgeranylated RhoB is sufficient to mediate tissue-specific suppression of Akt kinase activity by farnesyltransferase inhibitors.
Liu A; Prendergast GC
FEBS Lett; 2000 Sep; 481(3):205-8. PubMed ID: 11007964
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of RhoB by CK1 impedes actin stress fiber organization and epidermal growth factor receptor stabilization.
Tillement V; Lajoie-Mazenc I; Casanova A; Froment C; Penary M; Tovar D; Marquez R; Monsarrat B; Favre G; Pradines A
Exp Cell Res; 2008 Sep; 314(15):2811-21. PubMed ID: 18590726
[TBL] [Abstract][Full Text] [Related]
20. Generation of a single chain antibody variable fragment (scFv) to sense selectively RhoB activation.
Chinestra P; Olichon A; Medale-Giamarchi C; Lajoie-Mazenc I; Gence R; Inard C; Ligat L; Faye JC; Favre G
PLoS One; 2014; 9(11):e111034. PubMed ID: 25365345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
